1997
DOI: 10.1016/s0065-2776(08)60885-8
|View full text |Cite
|
Sign up to set email alerts
|

Proteasomes and Antigen Processing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
79
0

Year Published

1997
1997
2007
2007

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 107 publications
(80 citation statements)
references
References 120 publications
1
79
0
Order By: Relevance
“…Recently PA28 has been implicated as a regulator of immune function (Tanaka et al 1997). Intriguingly, PA28a (equivalent to the originally described PA28/ 11S regulator) is identical to IGUP I-5111, which is one of the major gene products induced by g-IFN in primary human keratinocytes (Honoré et al 1993).…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…Recently PA28 has been implicated as a regulator of immune function (Tanaka et al 1997). Intriguingly, PA28a (equivalent to the originally described PA28/ 11S regulator) is identical to IGUP I-5111, which is one of the major gene products induced by g-IFN in primary human keratinocytes (Honoré et al 1993).…”
Section: Discussionmentioning
confidence: 98%
“…Previously, we (Akiyama et al 1994;Hisamatsu et al 1996) and others (Belich et al 1994;Früh et al 1994) suggested that g-IFN may induce replacements of the three proteasome subunits X (MB1), Y (delta), and Z, by very homologous, but different, subunits named LMP7, LMP2 and MECL1, respectively, producing proteasomes that are perhaps responsible for the immunological processing of endogenous antigens. Therefore we propose the term 'immunoproteasomes' to indicate distinct proteasomes induced by g-IFN (Tanaka et al 1997). This idea is based on the findings that g-IFN induced not only a marked increase in both mRNA and protein levels of LMP7, LMP2 and MECL1, but also almost complete loss of the proteins X, Y and Z without affecting their mRNA levels.…”
Section: Discussionmentioning
confidence: 99%
“…It is known that two MHC-encoded proteasomal subunits, LMP2 and LMP7, have a polymorphism, but so far there has been no evidence which has indicated a relationship between their polymorphic nature and catalytic mode (Monaco & Nandai 1995). Moreover, 'immunoproteasomes' containing interferon-g inducible subunits such as LMP2, LMP7 and MECL1, are found to alter their cleavage specificity to produce efficiently immunodominant MHC class I ligands (York & Rock 1996;Groettrup et al 1996a;Tanaka et al 1997). This seems to be an adaptive change which was acquired during vertebrate evolution to accelerate the immune response, and differs from species specificity.…”
Section: Discussionmentioning
confidence: 99%
“…The major target proteins degraded by this enzyme must first be modified by covalent conjugation to a polyubiqutin chain as a degradation signal (Hochstrasser 1997). The ubiquitin-proteasome system has been implicated as a processing enzyme, generating immunodominant MHC ligands from endogenous antigens (Monaco & Nandai 1995;Groettrup et al 1996a;Tanaka et al 1997).…”
Section: Introductionmentioning
confidence: 99%
“…Ubiquitinmediated proteolysis is also required at many stages in the cell cycle (20) and in the elimination of specific proteins during DNA repair (21,22). Indeed, ubiquitin-mediated proteolysis has been implicated in processes as diverse as antigen presentation on major histocompatibility complex class I molecules (23)(24)(25) and proper telomere behavior during cell division (26). Discovering how polyubiquitin chains are recognized by the 26 S protease is central to understanding a number of regulatory mechanisms.…”
mentioning
confidence: 99%